Nanhua Cost Of Revenue from 2010 to 2024

000504 Stock   10.27  0.02  0.20%   
Nanhua Bio's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Overall, Cost Of Revenue is expected to go to about 69.4 M this year. From 2010 to 2024 Nanhua Bio Cost Of Revenue quarterly data regression line had arithmetic mean of  43,711,996 and r-squared of  0.25. View All Fundamentals
 
Cost Of Revenue  
First Reported
2002-06-30
Previous Quarter
10.4 M
Current Value
9.9 M
Quarterly Volatility
21.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nanhua Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanhua Bio's main balance sheet or income statement drivers, such as Interest Expense of 10.7 M, Selling General Administrative of 43 M or Total Revenue of 117.7 M, as well as many indicators such as . Nanhua financial statements analysis is a perfect complement when working with Nanhua Bio Valuation or Volatility modules.
  
This module can also supplement various Nanhua Bio Technical models . Check out the analysis of Nanhua Bio Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Nanhua Stock

Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.